Stock Screener App

Frei -

Installieren

35.94

1.37% -0.50

Xenon Pharmaceuticals Inc (XENE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	9.64% 123.16	112.33	109.77	96.34	94.23
Depreciation and Amortization	4.94% 0.558	0.587	0.611	0.641	0.632
Operating Income/Loss	9.64% -123.16	-112.33	-109.77	-96.34	-94.23
Nonoperating Income/Loss	58.74% 11.83	7.455	5.044	6.117	8.897
Income/Loss From Continuing Operations Before Tax	6.15% -111.32	-104.87	-104.72	-90.22	-85.33
Income Tax Expense/Benefit, Deferred	534.90% -1.944	0.447	-1.114	-0.701	-0.17
Income Tax Expense/Benefit	77.25% -0.585	-2.571	0.538	0.677	-0.626
Net Income/Loss	8.24% -110.74	-102.30	-105.26	-90.90	-84.71
Basic Average Shares	14.04% 99.61	87.35	0.2908	79.25	78.95
Diluted Average Shares	14.04% 99.61	87.35	0.2908	79.25	78.95
Basic Earnings Per Share	5.13% -1.11	-1.17	-1.31	-1.15	-1.07
Diluted Earnings Per Share	5.13% -1.11	-1.17	-1.31	-1.15	-1.07

TARS

$74.67

2.06%

IDYA

$36.30

0.51%

LEGN

$18.21

2.20%

PBLS

$28.74

4.59%

ACAD

$19.55

1.14%

VKTX

$28.39

0.42%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters